Bibliography
Filters: First Letter Of Keyword is D [Clear All Filters]
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106(7). Abstract
Ethical issues in preparing and publishing systematic reviews. J Evid Based Med. 2011;4(2):130-4.
Constructing a systematic review for argument-based clinical ethics literature: the example of concealed medications. J Med Philos. 2007;32(1):65-76. Abstract
Poor reporting and inadequate searches were apparent in systematic reviews of adverse effects. J Clin Epidemiol. 2008;61(5):440-8. Abstract
Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy. J Clin Oncol. 2013;31(20):2580-5. Abstract
Systematic collection of patient-reported adverse drug reactions: a path to patient-centred pharmacovigilance. Drug Saf. 2013;36(4):277-8.
Health technology assessment use and dissemination by patient and consumer groups: why and how? Int J Technol Assess Health Care. 2008;24(4):473-80. Abstract
Search strategies to identify information on adverse effects: a systematic review. J Med Libr Assoc. 2009;97(2):84-92. Abstract
Sources of information on adverse effects: a systematic review. Health Info Libr J. 2010;27(3):176-90. Abstract
Identifying systematic reviews of the adverse effects of health care interventions. BMC Med Res Methodol. 2006;6(22). Abstract
Unpublished data can be of value in systematic reviews of adverse effects: methodological overview. J Clin Epidemiol. 2010;63(10):1071-81. Abstract
Identifying systematic reviews of the adverse effects of health care interventions. BMC Med Res Methodol. 2006;6(22). Abstract
Search strategies to identify information on adverse effects: a systematic review. J Med Libr Assoc. 2009;97(2):84-92. Abstract
Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature. Appl Health Econ Health Policy. 2013;11(4):319-29. Abstract
The politics of health technology assessment in Poland. Health Policy. 2012;108(2-3):178-93. Abstract
Systematic reviews of adverse effects: framework for a structured approach. BMC Med Res Methodol. 2007;7:32. Abstract
Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions. Health Policy. 2012;108(2-3):167-77. Abstract
Populating decision-analytic models: the feasibility and efficiency of database searching for individual parameters. Int J Technol Assess Health Care. 2005;21(3):305-11. Abstract
Medicines regulation and health technology assessment. Clin Pharmacol Ther. 2010;87(2):152-4. Abstract
The politics of health technology assessment in Poland. Health Policy. 2012;108(2-3):178-93. Abstract
Unpublished data can be of value in systematic reviews of adverse effects: methodological overview. J Clin Epidemiol. 2010;63(10):1071-81. Abstract
Systematic reviews of adverse effects: framework for a structured approach. BMC Med Res Methodol. 2007;7:32. Abstract
Health care technology assessment in The Netherlands. Int J Technol Assess Health Care. 1990;6(1):157-63.
Toward patient-centered drug development in oncology. N Engl J Med. 2013;369(5):397-400.